BioTech
How biotech investors spot opportunity when stocks are down — and up
Following a blockbuster year of dealmaking and a recent uptick in biotech stocks, top investors see more good news on the horizon. Driving the momentum?
Allison DeAngelis and Mario Aguilar
March 22, 2024